Transforming drug screening technology

改变药物筛选技术

• 批准号: LP160100635
• 负责人: Prof Alastair Stewart
• 金额: $ 38.39万
• 依托单位: The University of Melbourne
• 依托单位国家: 澳大利亚
• 项目类别: Linkage Projects
• 财政年份: 2016
• 资助国家: 澳大利亚
• 起止时间: 2016-12-15 至 2019-12-14
• 项目状态: 已结题
• 来源: https://dataportal.arc.gov.au/RGS/Web/Grants/LP160100635
• 关键词: Transforming; drug; screening; technology

Transforming drug screening technology. This project aims to develop field-leading microchip technology, including the ability to measure contraction of micro-tissues on a chip. Micro-chip technology is in its infancy for use in drug discovery. However, interest in development and applications in Pharma and Biotech industries is immense. The project is intended to take proof-of-concept studies through to the “working model” stage and then to a level of industry-utility, focussing on predictive value, reproducibility and throughput. Successful development of the drug discovery micro-fluidics chip is expected to improve efficiency, reduce the costs and the use of experimental animals.

改变药物筛选技术。该项目旨在开发领域领先的微芯片技术，包括测量芯片上微组织收缩的能力。微芯片技术在药物发现中的应用尚处于起步阶段。然而，人们对制药和生物技术行业的开发和应用的兴趣是巨大的。该项目旨在将概念验证研究推进到“工作模型”阶段，然后达到行业实用水平，重点关注预测价值、再现性和吞吐量。药物发现微流控芯片的成功开发有望提高效率、降低成本和实验动物的使用。